Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MGNX
#3184
MacroGenics, Inc.
1.9
9
+1.53%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+1.53%
Mudança mensal
+8.15%
Mudança em 6 meses
+13.71%
Mudança anual
-17.43%
Fechamento anterior
1.9
6
Open
1.9
9
Bid
Ask
Low
1.9
9
High
1.9
9
Volume
16
Mercados
Ações
Cuidados de saúde
MGNX
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
56.26 M
61.32 M
61.84 M
62.43 M
63.09 M
—
Valuation ratios
Enterprise value
1.1 B
860.79 M
284.41 M
534.6 M
22.2 M
-71.3 M
Price to earnings ratio
—
-4.76
-3.26
-67.87
-3.04
-8.05
Price to sales ratio
—
12.42
2.57
10.73
1.36
3.17
Price to cash flow ratio
—
-6.69
-4.49
-8.06
-2.98
-5.83
Price to book ratio
—
4.02
2.75
4.13
1.75
2.52
Enterprise value to EBITDA ratio
—
37.36
2.8
34.06
0.26
-0.59
Profitability ratios
Return on assets %
0.34
0.6
0.43
0.03
0.26
0.02
Return on equity %
0.44
0.84
0.84
0.06
0.58
0.71
Return on invested capital %
338.26
510.33
323.56
442.07
386.54
—
Gross margin %
100
96.58
97.79
98.95
99.44
398.8
Operating margin %
124.96
261.85
79.91
286.38
73.74
226.96
EBITDA margin %
—
29.75
66.81
26.72
57.12
153.49
Net margin %
123.7
260.97
78.82
15.42
44.66
-5.08
Liquidity ratios
Quick ratio
—
3.69
4.54
4.46
3.92
17.07
Current ratio
6.17
3.75
4.57
4.48
3.92
17.68
Inventory turnover
—
0.6
1.15
0.46
1.39
0.14
Asset turnover
0.3
0.22
0.49
0.2
0.54
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
2.4
1.42
1.26
1.09
2.58
EBIT per share
—
0.2
1.46
0.1
1.25
1.1
EBITDA per share
—
0.38
1.65
0.25
1.37
1.22
Total debt per share
—
—
—
—
—
—
Cash per share
—
2.06
1.77
1.63
2.92
8.57
Net current asset value per share
—
4.66
3.62
4.06
3.47
13.28
Tangible book value per share
—
4
2.31
2.46
1.85
4.91
Working capital per share
—
3.42
2.83
3.15
2.59
10.19
Book value per share
—
4
2.31
2.46
1.85
4.91
Notícias
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
Ações da MacroGenics caem após FDA impor suspensão clínica parcial
MacroGenics stock falls after FDA places partial clinical hold
Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes
FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children
Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates
Lucro da MacroGenics Inc superou projeções por $0,68; receita supera estimativas
MacroGenics Inc earnings beat by $0.68, revenue topped estimates
MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Stryker (SYK) Q3 Earnings and Revenues Beat Estimates